[Cladribine in chronic progressive multiple sclerosis].
Weilbach
F X
FX
Klinische Forschungsgruppe für Multiple Sklerose, Julius-Maximilians-Universität Würzburg.
Hartung
H P
HP
D017338:Cladribine / Q000008:administration & dosage* / Q000009:adverse effects; D018592:Cross-Over Studies; D004185:Disability Evaluation; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D006801:Humans; D015918:Infusion Pumps, Implantable; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D009460:Neurologic Examination / Q000187:drug effects
D017338:Cladribine
Cladribin bei chronisch progredienter multipler Sklerose.